Immunitybio, Inc.
IBRX
Revenue
38.29M
▲6.22M▲19.41%
3 Months ChangeAssets
501.90M
▼-17.09M▼-3.29%
3 Months ChangeLiabilities
1.00B
▼-40.93M▼-3.93%
3 Months ChangeFree Cash Flow
-87.03M
▲21.22M▲19.60%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2026-02-23
Form 8-K
ID: 0001326110-26-000025
2026-02-18
Form 8-K
ID: 0001326110-26-000018
2026-01-26
Form 8-K
ID: 0001326110-26-000014
2026-01-15
Form 8-K
ID: 0001326110-26-000008
2026-01-14
Form 8-K
ID: 0001326110-26-000004
2025-12-29
Form 8-K
ID: 0001193125-25-331244
2025-12-15
Form 8-K
ID: 0001326110-25-000146
2025-12-12
Form 8-K
ID: 0001326110-25-000143
2025-11-05
Form 10-Q
ID: 0001326110-25-000139
2025-11-05
Form 8-K
ID: 0001326110-25-000138